Vol 2, No 3 (2010)
Mol Cell Pharmacol
Table of Contents
PharmSights
| Cyclosporin A Enhances Cell Survival in Neural Precursor Populations in the Adult Central Nervous System | Abstract PDF |
| Jessica Hunt, Cindi Morshead | 81-88 |
| DP2 Receptor Antagonists: Novel Therapeutic Target for COPD | Abstract PDF |
| Karin J. Stebbins, Jilly F. Evans, Daniel S. Lorrain | 89-96 |
| Implications of a Newly Discovered DR5 Specific Antagonistic Peptide for Neurodegenerative Disorders | Abstract PDF |
| Mariette S. Heins, Wim J. Quax | 97-100 |
Research Articles
| Mitochondrial and Plasma Membrane Citrate Transporters: Discovery of Selective Inhibitors and Application to Structure/Function Analysis | Abstract PDF |
| Jiakang Sun, Sreevidya Aluvila, Rusudan Kotaria, June A. Mayor, D. Eric Walters, Ronald S. Kaplan | 101-110 |
Reviews
| G Protein-Coupled Receptor 87: a Promising Opportunity for Cancer Drug Discovery | Abstract PDF |
| Yanhong Zhang, Ariane Scoumanne, Xinbin Chen | 111-116 |
| The “Two faces” of Tumor Suppressor p53-revisited | Abstract PDF |
| Martin L. Smith, M.A. Suresh Kumar | 117-119 |
FDA Corner
| FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women | Abstract PDF |
| 121 |
| FDA Approves New Treatment for Late-Onset Pompe Disease | Abstract PDF |
| 121-122 |
| FDA Approves New Combination Product Oral Contraceptive | Abstract PDF |
| 122 |
| FDA Approves a Cellular Immunotherapy for Men with Advanced Prostate Cancer | Abstract PDF |
| 122-123 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.